IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i4p3752-d1074644.html
   My bibliography  Save this article

Association between Glutathione S-Transferases Gene Variants and COVID-19 Severity in Previously Vaccinated and Unvaccinated Polish Patients with Confirmed SARS-CoV-2 Infection

Author

Listed:
  • Katarzyna Orlewska

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Justyna Klusek

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Dorota Zarębska-Michaluk

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Kamila Kocańda

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Ruslan Oblap

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Anna Cedro

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Bartosz Witczak

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

  • Jolanta Klusek

    (Institute of Biology, Jan Kochanowski University, 25-406 Kielce, Poland)

  • Andrzej Śliwczyński

    (Faculty of Medicine, Lazarski University, 02-662 Warsaw, Poland
    Central Clinical Hospital of the Ministry of Interior and Administration, 02-507 Warsaw, Poland)

  • Ewa Orlewska

    (Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, Poland)

Abstract

As the outcome of COVID-19 is associated with oxidative stress, it is highly probable that polymorphisms of genes related to oxidative stress were associated with susceptibility and severity of COVID-19. The aim of the study was to assess the association of glutathione S-transferases (GSTs) gene polymorphisms with COVID-19 severity in previously vaccinated and unvaccinated Polish patients with confirmed SARS-CoV-2 infection. A total of 92 not vaccinated and 84 vaccinated patients hospitalized due to COVID-19 were included. The WHO COVID-19 Clinical Progression Scale was used to assess COVID-19 severity. GSTs genetic polymorphisms were assessed by appropriate PCR methods. Univariable and multivariable analyses were performed, including logistic regression analysis. GSTP1 Ile/Val genotype was found to be associated with a higher risk of developing a severe form of the disease in the population of vaccinated patients with COVID-19 (OR: 2.75; p = 0.0398). No significant association was observed for any of the assessed GST genotypes with COVID-19 disease severity in unvaccinated patients with COVID-19. In this group of patients, BMI > 25 and serum glucose level > 99 mg% statistically significantly increased the odds towards more severe COVID-19. Our results may contribute to further understanding of risk factors of severe COVID-19 and selecting patients in need of strategies focusing on oxidative stress.

Suggested Citation

  • Katarzyna Orlewska & Justyna Klusek & Dorota Zarębska-Michaluk & Kamila Kocańda & Ruslan Oblap & Anna Cedro & Bartosz Witczak & Jolanta Klusek & Andrzej Śliwczyński & Ewa Orlewska, 2023. "Association between Glutathione S-Transferases Gene Variants and COVID-19 Severity in Previously Vaccinated and Unvaccinated Polish Patients with Confirmed SARS-CoV-2 Infection," IJERPH, MDPI, vol. 20(4), pages 1-11, February.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:4:p:3752-:d:1074644
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/4/3752/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/4/3752/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Erola Pairo-Castineira & Sara Clohisey & Lucija Klaric & Andrew D. Bretherick & Konrad Rawlik & Dorota Pasko & Susan Walker & Nick Parkinson & Max Head Fourman & Clark D. Russell & James Furniss & Ann, 2021. "Genetic mechanisms of critical illness in COVID-19," Nature, Nature, vol. 591(7848), pages 92-98, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Shelly J. Robertson & Olivia Bedard & Kristin L. McNally & Carl Shaia & Chad S. Clancy & Matthew Lewis & Rebecca M. Broeckel & Abhilash I. Chiramel & Jeffrey G. Shannon & Gail L. Sturdevant & Rebecca , 2023. "Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    2. Elsa Brunet-Ratnasingham & Sacha Morin & Haley E. Randolph & Marjorie Labrecque & Justin Bélair & Raphaël Lima-Barbosa & Amélie Pagliuzza & Lorie Marchitto & Michael Hultström & Julia Niessl & Rose Cl, 2024. "Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    3. Victoria N. Parikh & Alexander G. Ioannidis & David Jimenez-Morales & John E. Gorzynski & Hannah N. Jong & Xiran Liu & Jonasel Roque & Victoria P. Cepeda-Espinoza & Kazutoyo Osoegawa & Chris Hughes & , 2022. "Deconvoluting complex correlates of COVID-19 severity with a multi-omic pandemic tracking strategy," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    4. Thomas Liechti & Yaser Iftikhar & Massimo Mangino & Margaret Beddall & Charles W. Goss & Jane A. O’Halloran & Philip A. Mudd & Mario Roederer, 2022. "Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    5. Tomoko Nakanishi & Julian Willett & Yossi Farjoun & Richard J. Allen & Beatriz Guillen-Guio & Darin Adra & Sirui Zhou & J. Brent Richards, 2023. "Alternative splicing in lung influences COVID-19 severity and respiratory diseases," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    6. Benjamin J. Schmiedel & Job Rocha & Cristian Gonzalez-Colin & Sourya Bhattacharyya & Ariel Madrigal & Christian H. Ottensmeier & Ferhat Ay & Vivek Chandra & Pandurangan Vijayanand, 2021. "COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types," Nature Communications, Nature, vol. 12(1), pages 1-12, December.
    7. Maik Pietzner & Robert Lorenz Chua & Eleanor Wheeler & Katharina Jechow & Julian D. S. Willett & Helena Radbruch & Saskia Trump & Bettina Heidecker & Hugo Zeberg & Frank L. Heppner & Roland Eils & Mar, 2022. "ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    8. Yvonne M. Mueller & Thijs J. Schrama & Rik Ruijten & Marco W. J. Schreurs & Dwin G. B. Grashof & Harmen J. G. van de Werken & Giovanna Jona Lasinio & Daniel Álvarez-Sierra & Caoimhe H. Kiernan & Melis, 2022. "Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learning," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    9. Guillermo Barturen & Elena Carnero-Montoro & Manuel Martínez-Bueno & Silvia Rojo-Rello & Beatriz Sobrino & Óscar Porras-Perales & Clara Alcántara-Domínguez & David Bernardo & Marta E. Alarcón-Riquelme, 2022. "Whole blood DNA methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection," Nature Communications, Nature, vol. 13(1), pages 1-11, December.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:4:p:3752-:d:1074644. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.